Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.

Slides:



Advertisements
Similar presentations
WHOLE-BODY-LOW-DOSE MDCT IN THE INVESTIGATION OF MULTIPLE MYELOMA (MM) – A NEW APPROCH AND OUR EXPERIENCE Kamenetsky Natalya (1), Rachmilewitz Eliezer.
Advertisements

Multiple Myeloma By Dr Sameh Shamaa. Multiple Myeloma Epidemiology: 1% Of all malignant diseases. Annual incidence: 3-4/ Age: - Median age: 65y.
Serum Electrophoresis AND IMMUNOFIXATION june 2013 Dr. Nitin A Inamdar Department of Biochemistry Tata Memorial Center
Rick Allen.  A malignant proliferation of plasma cells derived from a single clone, with multifocal involvement of the skeleton.
Tabuk University 1 3 rd Year – Level 5 – AY Faculty of Applied Medical Sciences Department Of Medical Lab. Technology.
Show and Tell FIRM B - RED. Our team Dr. Clarke & Dr. Vargas Shinoj & Arvind Jacob & Muneeza Chloe, Lauren & Njiye.
Serum Protein Electrophoresis
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Dr A. Mousavi.  15 % of all malignant white cell diseases  1% of all cancer deaths  Group of lymphoid neoplasms of terminally differentiated B-cells.
Chapter 21 Monoclonal Gammopathies
CLS 404 Immunology Protein Abnormalities
Diagnosis of Paraprotein Diseases CLS 404 Immunology Protein Abnormalities.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Week 11: Lymphoproliferative Disorders Multiple myeloma Multiple myeloma Plasma cell Plasma cell Monoclonal gammopathy Monoclonal gammopathy Bence-Jones.
Tumor Markers Michael A. Pesce, PhD Department of Pathology Columbia-Presbyterian Medical Center.
Lymphomas Clonal disorders of lymphoid cells at various stages of differentiation HODGKIN L. NON-HODGKIN L.  immature cells (precursors)  mature cells.
Terry Kotrla, MS, MT(ASCP)BB Topic 3 Autoimmunity Part 8 Immunoproliferative Diseases.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
MULTIPLE MYELOMA (MM).
Diagnosis and Treatment of Multiple Myeloma Mark B. Juckett MD Division of Hematology University of Wisconsin December 11, 2002.
Multiple Myeloma Alan Johns, M.D. Kristine Krafts, M.D.
Case Diagnostic Slide Session AANP - Annual Meeting Saturday, June 23, 2012 David Pisapia, M.D. Neuropathology Fellow Department of Pathology.
Multiple Myeloma Definition:
Clinical interpretation of Serum Free Light Chain assays 22 Feb 2013 Dr. Eric Chan Consultant Immunologist Queen Mary Hospital Hong Kong.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
IMMUNOCHEMISTRY PROFILES Dr. Thomas Williams. TESTS DISEASES CASES.
Multiple Myeloma Definition:
Plasma Cell Disorders Kristi McIntyre M.D. Texas Oncology 2004 Monoclonal Gammopathies.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria MULTIPLE MYELOMA.
Epidemiology 12,000 deaths in United States per year
CASE 5 56 yr-old man HIV Asymptomatic CD4 840 HIV viral load
1.Defining Plasma cell disorders/Multiple Myeloma 2.Identification of different plasma cell disorders. 3.Diagnosis and workup for plasma cell disorders/Multiple.
Immune response against tumors
LYMPHOPROLIFERATIVE DISORDERS
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
MLAB 1415: H EMATOLOGY K ERI B ROPHY -M ARTINEZ Chapter 26: Lymphoid Malignancies Part Two.
Biological functions transport –albumin –transferin –ceruloplasmin –haptoglobin oncotic pressure regulation coagulation immunity.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Jesse C James MD AM Report May 7,  Proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein  Malignant.
Chicago Medical School
Dr Samal Nauhria .edu Plasma cell lesions Dr Samal Nauhria .edu.
Plasma cell Dyscrasia 1- B.M.G. 2- Multiple Myeloma 3- Waldenstrom Macroglubolenemia 4- Heavy Chain disease 5- Amyloidosis.
상복부 통증을 주소로 내원한 46 세 여자 환 자 연세대학교 원주의과대학 원주기독병원 소화기내과, 1 병리과 석기태, 김재우, 조미연 1, 김현수.
Plasma Cell Dyscrasis Sanambar Sadighi Hematologist-Oncologist Cancer Institute.
M. Multiple Myeloma Malignant proliferation of plasma cells. Malignant proliferation of plasma cells. Normal plasma cell form Ig which contain heavy and.
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
Para-proteinaemias Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor 7 th march 2016.
May 13, 2016 Dr Sindu Kanjeekal MD FRCPC
R4 Jae Joon Han.
CONCEPT MAP CONCEPT MAP. 42 y/o male, CC: EDEMA ON BILATERAL EXTREMITIES. Diagnosed with a benign cystic lesion 8 yrs ago S/Sx: BONE PAINS, EASY FATIGUABILITY.
Miten R. Patel, MD Cancer Specialists of North Florida
Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor
Paraproteinaemias. Multiple myeloma. Amyloidosis. Part 2 Dr
MULTIPLE MYELOMA (MM) objective: definition of MM Biochemical investigation in Diagnosis.
MLAB Hematology Keri Brophy-Martinez
Lymphoproliferative disorders
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Anaplastic variant of plasma cell myeloma with Dutcher bodies
Multiple myeloma (MM) & related disorders
by Qin Huang Blood Volume 122(1):6-6 July 4, 2013
Rare and strange invader
PARAPRTEINAEMIA and MULTIPLE MYELOMA
LYMPHOPROLIFERATIVE DISORDERS
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk.
Bence Jones protein The Bence Jones protein was described by the English physician Henry Bence Jones in 1847 and published in 1848.Henry Bence Jones The.
Presentation transcript:

Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy

Multiple Myeloma Bone marrow based Median age 70 Multifocal, bone, tumor masses Serum paraprotein, Urine Bence-Jones protein Osteolytic lesions, bone pain, hyper calcemia, anemia Renal failure

Morphology –Increased plasma cells ( mature, immature and anaplastic) –Mass of plasma cells –Ig inclusions Immuno: CD20 neg, cytoplasmic Ig IgG>IgA

Lambda

Plasmacytoma Localized osseous or extra osseous plasma cell tumor

kappa

Monoclonal Gammopathy of Undetermined Significance MGUS Asymptomatic M protein (less than myeloma) BM Plasmacytosis <10% 25% progress to Multiple Myeloma

Lymphoplasmacytic lymphoma B cell lymphoma Leukemic with bone marrow involvement Low grade Paraprotein IgM Waldensrom macroglobulinemia

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.